Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A confidence set inference procedure for gene mapping using markers with incomplete polymorphism.

Charalampos Papachristou1, Shili Lin

  • 1Department of Statistics, Ohio State University, Columbus, Ohio, USA.

Human Heredity
|April 2, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Workspace and trajectory-based experimental validation of a 3-armed 6-DOF parallel robot for femoral fracture surgery.

Frontiers in robotics and AI·2026
Same author

Short-Term Combined Tat-Beclin1 and Endurance Training Improves Age-Related Decline in Physical Function in Male Mice.

bioRxiv : the preprint server for biology·2026
Same author

Refining the Definition for "Low Risk" in Pulmonary Arterial Hypertension: Time to Reduce Morbidity and Mortality.

JACC. Heart failure·2026
Same author

Reply to Blette and Kawut: Surrogate Endpoints are Risky Business in Pulmonary Arterial Hypertension.

American journal of respiratory and critical care medicine·2026
Same author

szKendall: spatial-structural-zero-aware dissimilarity measures for subtype discovery using single cell Hi-C data.

Nature communications·2026
Same author

Study of risk assessment scores as surrogate endpoints in pulmonary arterial hypertension trials.

American journal of respiratory and critical care medicine·2026

This study introduces an improved confidence set inference (CSI) method for gene mapping, enhancing its use with incomplete genetic markers. The extended CSI procedure offers practical advantages for localizing disease genes.

Area of Science:

  • Genetics
  • Statistical genetics
  • Bioinformatics

Background:

  • Confidence Set Inference (CSI) is a gene mapping approach with advantages like avoiding multiple testing corrections and providing reliable confidence intervals.
  • Existing CSI methods have limitations when dealing with genetic markers exhibiting incomplete polymorphism.
  • Accurate gene mapping is crucial for understanding disease etiology and developing targeted therapies.

Purpose of the Study:

  • To extend the Confidence Set Inference (CSI) procedure to accommodate genetic markers with incomplete polymorphism.
  • To evaluate the performance of the extended CSI method through simulation studies.
  • To assess the impact of relative risk estimates and complex disease models on CSI performance.

Main Methods:

  • Developed an extended Confidence Set Inference (CSI) procedure to handle markers with incomplete polymorphism.

Related Experiment Videos

  • Conducted simulation studies to compare the extended CSI with the original method.
  • Investigated the influence of varying relative risk estimates and different genetic models (single-locus and two-locus) on statistical power and type I error rates.
  • Applied the extended CSI method to real-world data from the Genetic Analysis Workshop 13 (GAW13).

    • Main Results:

    • The extended CSI procedure successfully handles markers with incomplete polymorphism, broadening its practical applicability.
    • Simulation results indicate that the new procedure maintains the core advantages of CSI, though it may require more data for equivalent statistical power, especially with lower marker heterozygosity.
    • Perturbations in relative risk estimates or the use of multilocus disease models generally decreased power or increased type I error rates.
    • The extended CSI demonstrated robust performance for certain two-locus disease models, achieving high coverage probabilities for disease loci.
    • Application to GAW13 data yielded favorable results, comparable to established methods like GENEHUNTER's NPL sib-pair analysis.

    Conclusions:

    • The extended CSI method effectively addresses the challenge of incomplete polymorphism in genetic markers, enhancing its utility in gene mapping studies.
    • The extended CSI retains the statistical benefits of the original method while expanding its applicability to more realistic genetic scenarios.
    • The study highlights the importance of accurate genetic marker data and appropriate disease models for optimal performance of CSI-based gene mapping.
    • The extended CSI method shows promise as a valuable tool for disease gene localization, offering competitive performance against existing approaches.